143 related articles for article (PubMed ID: 30868094)
1. Sensory Tricks for Cervical Levodopa-induced Dyskinesia in Patients with Parkinson's Disease.
Shin HW; Ryu HS; Kim J; Kim MJ; Hallett M; Chung SJ
Mov Disord Clin Pract; 2017; 4(1):138-140. PubMed ID: 30868094
[TBL] [Abstract][Full Text] [Related]
2. Sensory tricks in primary blepharospasm and idiopathic cervical dystonia.
Pandey S; Soni G; Sarma N
Neurol India; 2017; 65(3):532-536. PubMed ID: 28488615
[TBL] [Abstract][Full Text] [Related]
3. Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatment.
Zesiewicz TA; Sullivan KL; Hauser RA
Curr Neurol Neurosci Rep; 2007 Jul; 7(4):302-10. PubMed ID: 17618536
[TBL] [Abstract][Full Text] [Related]
4. Sensory Tricks in Pantothenate Kinase-Associated Neurodegeneration: Video-Analysis of 43 Patients.
Martins J; Darling A; Garrido C; Espinós C; Martí MJ; Dueñas BP; Temudo T
Mov Disord Clin Pract; 2019 Nov; 6(8):704-707. PubMed ID: 31745482
[TBL] [Abstract][Full Text] [Related]
5. Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study.
Choudhury S; Pradhan R; Paul P; Das M; Gupta A; Ghosh P; Chatterjee S
Neurol Res; 2014 Sep; 36(9):841-6. PubMed ID: 24601722
[TBL] [Abstract][Full Text] [Related]
6. Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.
Vijayakumar D; Jankovic J
Drugs; 2016 May; 76(7):759-77. PubMed ID: 27091215
[TBL] [Abstract][Full Text] [Related]
7. Sensory tricks modulate corticocortical and corticomuscular connectivity in cervical dystonia.
Lee SW; Cho HJ; Shin HW; Hallett M
Clin Neurophysiol; 2021 Dec; 132(12):3116-3124. PubMed ID: 34749232
[TBL] [Abstract][Full Text] [Related]
8. Sensory tricks in cervical dystonia correlate with enhanced brain activity during motor preparation.
Shin HW; Cho HJ; Lee SW; Shitara H; Hallett M
Parkinsonism Relat Disord; 2021 Mar; 84():135-138. PubMed ID: 33611075
[TBL] [Abstract][Full Text] [Related]
9. Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot?
Vidailhet M; Bonnet AM; Marconi R; Gouider-Khouja N; Agid Y
Neurology; 1994 Sep; 44(9):1613-6. PubMed ID: 7936284
[TBL] [Abstract][Full Text] [Related]
10. Brain-Region Specific Metabolic Abnormalities in Parkinson's Disease and Levodopa-Induced Dyskinesia.
Yang C; Zhang T; Wang W; Xiang Y; Huang Q; Xie C; Zhao L; Zheng H; Yang Y; Gao H
Front Aging Neurosci; 2020; 12():75. PubMed ID: 32256342
[TBL] [Abstract][Full Text] [Related]
11. Force overflow and levodopa-induced dyskinesias in Parkinson's disease.
Wenzelburger R; Zhang BR; Pohle S; Klebe S; Lorenz D; Herzog J; Wilms H; Deuschl G; Krack P
Brain; 2002 Apr; 125(Pt 4):871-9. PubMed ID: 11912119
[TBL] [Abstract][Full Text] [Related]
12. Sensory Tricks Are Associated with Higher Sleep-Related Quality of Life in Cervical Dystonia.
Benadof CN; Cisneros E; Appelbaum MI; Stebbins GT; Comella CL; Peterson DA
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31413893
[TBL] [Abstract][Full Text] [Related]
13. Subthalamic oscillatory activity in parkinsonian patients with off-period dystonia.
Li X; Zhuang P; Hallett M; Zhang Y; Li J; Li Y
Acta Neurol Scand; 2016 Nov; 134(5):327-338. PubMed ID: 27696368
[TBL] [Abstract][Full Text] [Related]
14. Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.
Luquin MR; Scipioni O; Vaamonde J; Gershanik O; Obeso JA
Mov Disord; 1992; 7(2):117-24. PubMed ID: 1350058
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.
Yoo HS; Chung SJ; Chung SJ; Moon H; Oh JS; Kim JS; Hong JY; Ye BS; Sohn YH; Lee PH
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):423-431. PubMed ID: 29075830
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model.
Tronci E; Lisci C; Stancampiano R; Fidalgo C; Collu M; Devoto P; Carta M
Neurobiol Dis; 2013 Dec; 60():108-14. PubMed ID: 24004632
[TBL] [Abstract][Full Text] [Related]
17. Levodopa-induced ocular dyskinesia in Parkinson's disease.
Grötzsch H; Sztajzel R; Burkhard PR
Eur J Neurol; 2007 Oct; 14(10):1124-8. PubMed ID: 17880568
[TBL] [Abstract][Full Text] [Related]
18. Extended-Release Amantadine for Levodopa-Induced Dyskinesia.
Dashtipour K; Tafreshi AR; Pahwa R; Lyons KE
Expert Rev Neurother; 2019 Apr; 19(4):293-299. PubMed ID: 30892103
[TBL] [Abstract][Full Text] [Related]
19. Noradrenergic drugs for levodopa-induced dyskinesia.
Colosimo C; Craus A
Clin Neuropharmacol; 2003; 26(6):299-305. PubMed ID: 14646609
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Levetiracetam for the Management of Levodopa- Induced Dyskinesia in Patients with Parkinson's Disease: A Systematic Review.
Ebada MA; Alkanj S; Ebada M; Abdelkarim AH; Diab A; Aziz MAE; Soliman AM; Fayed N; Bahbah EI; Negida A
CNS Neurol Disord Drug Targets; 2019; 18(4):317-325. PubMed ID: 30868968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
